Gene Expression Market: Top Growth Pockets Promising Industry Dominance 2022-2026
The research community has been attracting huge government investments as the significance of genomics continues to grow worldwide. Global gene expression market is predominantly driven by the notable developments in genomic databases, says a new research intelligence study of Fairfield Market Research.
The report highlights that with the advent of
next-generation sequencing (NGS) techniques, demand for gene expression analysis
also continues to be on an upswing. Besides the critically soaring need for
effective carcer therapeutics, rising boom around personalised medicine, and an
increasing number of genetic conditions being diagnosed will largely contribute
toward the expansion of gene expression market. Gene expression analysis also gained
overnight traction amid COVID-19 risk factor detection as a vital step of
disease diagnostics.
Looking For a Sample Copy of This Report? Request the Same Here: https://www.fairfieldmarketresearch.com/report/gene-expression-market/request-sample
Demand for Gene Expression Analysis Surges as Cancer
Research and Therapeutics Take the Limelight
The
extraordinarily growing prevalence of cancers worldwide is likely to be the
leading factor pushing demand for gene expression analysis. It also has been
working to the advantage of the field of personalised medicine. While cancer therapeutics
and research continue to garner funds, and investments from across the globe, a
wide range of sequencing procedures are also gaining stronger ground – majorly
on the back of their consistently falling costs.
Gene
expression market is especially projected for a healthy growth outlook as gene
therapy has become one of the hottest areas of research luring investors,
governments, as well as medical industry alike. As the concept of precision
medicine firms up, the market for gene expression is all set to reap the
benefit in long run. Besides cancers, prevalence of rare diseases, and
inherited conditions continues to be on a higher side as well. This is also
expected to be among the important factors strengthening gene expression
market.
Leading Players in Global Gene Expression Market Space
Fairfield Market Research in its report would reveal
some exclusive insights on the leading companies stirring the global gene
expression market competition landscape. Some of the prominent players profiled
in the report, include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG,
Promega Corp., Biocartis NV, Bio-Rad Laboratories, Inc., Illumina, Inc.,
Agilent Technologies, QIAGEN N.V., GE Healthcare, Becton, Dickinson and
Company, PerkinElmer Inc., Oxford Gene Technology, Quest Diagnostics, Inc.,
Luminex Corp., Takara Bio, Inc., Interpace Biosciences, Inc., and AutoGenomics.
Clinical Diagnostics Holds the Promise to Unlock New
Opportunities
Gene expression has established itself as a sought-after
technology for applications in biotechnology, drug development and discovery,
microbiology, clinical diagnostics, pharmacogenomics, and toxicogenomics. While
the world of medicine is continuously longing for early, and accurate detection/diagnosis,
it will offer a strong impetus to the field of clinical diagnostics. This is
particularly projected to raise the application potential of RNA expression
analysis in clinical diagnostics, especially for rare genetic conditions in
premature infants, and early-onset infections (EOIs). Advent of stem cell
therapy, and genetic engineering further elevate the growth potential of gene
expression market.
Do
You Have Any Query or Specific Requirement? Request Customization of Report: https://www.fairfieldmarketresearch.com/report/gene-expression-market/request-customization
North
America Continues to Lead, Market Attractiveness of Asia Pacific Soars
Preliminary
findings of regional analysis of gene expression market suggests that North
America has been in the bandwagon in terms of generating demand for gene
expression analysis. The region will retain its top position globally on
account of the remarkable market of gene therapy. The market here is expected
to gain significantly from solid investments flowing into genetic research, favourable
government initiatives, and growing significance of NGS in the field of
diagnostics.
While
the US continues to spearhead North American market for gene expression, China
is at the forefront in Asia Pacific. China’s recombinant DNA technology
landscape has been highly dynamic and will remain the key factor driving gene
expression market in the region. Besides, the key Asian economies have been
witnessing an exponentially rising rate of cancer prevalence over the past
decade. The consequently expanding cancer research, and critically surging need
for cancer therapeutics is thus likely to fuel growth of gene expression market
across Asia Pacific.
About Us
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
Follow Us: LinkedIn
Comments
Post a Comment